Table 1 Patient characteristics
Characteristics | No. of patients (%) | |
|---|---|---|
Age (y) | ||
Range, 17–70 | ||
Median, 51 | ||
Histopathologic diagnosis (adenocarcinoma) | ||
Serous | 47/60 (78.3) | |
Others (endometrioid, mucinous) | 13/60 (21.7) | |
Normal (cancer-adjacent normal tissue) | 10 | |
Grade | ||
1 | 13/60 (21.7) | |
2 | 26/60 (43.3) | |
3 | 21/60 (35.0) | |
Disease stage | ||
I | 38/60 (63.3) | |
II | 18/60 (30.0) | |
III | 3/60 (5.0) | |
IV | 1/60 (1.7) | |
p-PEA15-S104 expression | ||
1 (low) | 12/60 (20.0) | 10/10 (100) |
2 (moderate) | 22/60 (36.7) | 0 |
3 (high) | 26/60 (43.3) | 0 |
p-PEA15-S116 expression | ||
1 (low) | 24/60 (40.0) | 1/10 (10) |
2 (moderate) | 20/60 (33.3) | 6/10 (60) |
3 (high) | 16/60 (26.7) | 3/10 (30) |
β-Catenin expression | ||
0 (no expression) | 5/60 (8.3) | 0 |
1 (low) | 34/60 (56.7) | 5/10 (50) |
2 (moderate) | 14/60 (23.3) | 5/10 (50) |
3 (high) | 7/60 (11.7) | 0 |
